Zotefoams PLC
12 July 2000
ZOTEFOAMS PLC
Board Changes
Notice of interim results
Zotefoams plc announces that Mr Randall Redd, President of the company's US
subsidiary Zotefoams Inc., has today resigned from the board in order to
pursue other business interests. Mr Mike Lewsey, Sales and Marketing Director
will assume his responsibilities in the US with immediate effect.
The company continues to make good progress towards the completion of its
global sales, marketing and technology alliance with Sekisui Chemical Company
Limited of Japan. A full update on this agreement will be provided when
Zotefoams announces its interim results for the 6 months ended 30 June 2000 on
Tuesday 8 August 2000.
Enquiries:
Zotefoams 020 8664 1600
David Stirling, Managing Director
Financial Dynamics 020 7831 3113
Tom Baldock
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.